Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ECYT > SEC Filings for ECYT > Form 8-K on 31-Mar-2014All Recent SEC Filings

Show all filings for ENDOCYTE INC

Form 8-K for ENDOCYTE INC


31-Mar-2014

Entry into a Material Definitive Agreement, Financial Statements and Exhibits


Item 1.01 Entry into a Material Definitive Agreement.

On March 27, 2014, Endocyte, Inc. (the "Company") entered into an underwriting agreement (the "Underwriting Agreement") with Credit Suisse Securities (USA) LLC and Citigroup Global Markets Inc., as representatives of the underwriters named therein (collectively, the "Underwriters"), in connection with the public offering of up to 5,175,000 shares of the Company's common stock (the "Shares"). The sale of the Shares is expected to close on April 2, 2014, subject to customary closing conditions.

The offering of the Shares was made pursuant to the Registration Statement on Form S-3 (Registration No. 333-194791), the prospectus dated March 25, 2014, and the related prospectus supplement dated March 27, 2014.

A copy of the Underwriting Agreement is attached hereto as Exhibit 1.1 and is incorporated herein by reference.

The legal opinion of Faegre Baker Daniels LLP relating to the validity of the Shares sold in the public offering is filed as Exhibit 5.1 to this Current Report on Form 8-K.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.                           Exhibit Description

1.1            Underwriting Agreement, dated as of March 27, 2014, among the
               Company, Credit Suisse Securities (USA) LLC and Citigroup Global
               Markets Inc.
5.1            Opinion of Faegre Baker Daniels LLP.
23.1           Consent of Faegre Baker Daniels LLP (included in Exhibit 5.1).

  Add ECYT to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ECYT - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.